Patent assignee · US · COMPANY

Lumen Therapeutics, LLC

4Patents
4Active
4Granted
41Portfolio score

Filing activity: Apr 18, 2007 → Jan 11, 2014 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7557087B2 Compositions and methods for treating diseases Emerging Cross-Sectional Technologies 35 Active
US9220744B2 Compositions and methods for treating diseases Emerging Cross-Sectional Technologies 2 Active
US8629115B2 Compositions and methods for treating diseases Emerging Cross-Sectional Technologies 2 Active
US7820626B2 Compositions and methods for treating diseases Emerging Cross-Sectional Technologies 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.